Literature DB >> 29793858

Tralokinumab unsuccessful for management of severe, uncontrolled asthma.

Kian Fan Chung1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29793858     DOI： 10.1016/S2213-2600(18)30194-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

Review 1.  Role of Biologics in Asthma.

Authors:  Mary Clare McGregor; James G Krings; Parameswaran Nair; Mario Castro
Journal:  Am J Respir Crit Care Med       Date:  2019-02-15       Impact factor: 21.405

Review 2.  Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling.

Authors:  Grzegorz Kardas; Piotr Kuna; Michał Panek
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

Review 3.  Severe refractory asthma: current treatment options and ongoing research.

Authors:  Francesco Menzella; Francesca Bertolini; Mirella Biava; Carla Galeone; Chiara Scelfo; Marco Caminati
Journal:  Drugs Context       Date:  2018-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.